Adverse Events Following Transcatheter Edge-to-Edge Repair (TEER) Using MitraClip: Lessons Learned From the Manufacturer and User Facility Device Experience (MAUDE) Registry

• Published in: Cardiovascular revascularization medicine Vol. 39; pp. 101 - 105
• Main Authors: Dodoo, Sheriff N., Okoh, Alexis K., Oseni, Abdullahi, Odiete, Oghenerukevwe, Okafor, Henry E.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.06.2022
• Subjects: Adverse events; Databases, Factual; Fatal events; Humans; MitraClip; Registries; United States; United States Food and Drug Administration; United States; MitraClip; Adverse events; Fatal events

The MitraClip from Abbott is FDA approved intracardiac implantable device for transcatheter edge-to-edge repair (TEER). Despite a few previously published studies, there is limited safety data for its use in clinical practice, hence, we designed this study using data obtained from a safety nationwid...